CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- 4 Open-market sale Chief Commercial Officer sold 834 shares at $12.36 ($10,310)
- 4 Open-market sale Chief Medical Officer sold 1,026 shares at $12.36 ($12,683)
- 4 Open-market sale Chief Product Officer sold 1,064 shares at $12.36 ($13,153)
- 4 Open-market sale Chief Financial Officer sold 1,428 shares at $12.36 ($17,652)
- 4 Open-market sale President & CEO sold 3,384 shares at $12.36 ($41,832)
- S-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Grant or award Director acquired 3,997 shares (grant or award)
- 4 Grant or award Director acquired 3,997 shares (grant or award)
- 4 Grant or award Director acquired 3,997 shares (grant or award)
- 4 Grant or award Director acquired 3,997 shares (grant or award)
Page 6 of 15 · 290 filings